Biden has ambitious plans to curb the coronavirus. But they could face big hurdles in a divided country and Congress. Read more
An FDA advisory committee found there was not sufficient evidence to conclude an experimental Alzheimer’s disease drug is effective, raising questions about whether the agency will approve it. Read more